These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 5005131

  • 1. Clinical experiences in oral antidiabetic therapy with sulphonylureas and biguanides.
    Schöffling K.
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:47-56. PubMed ID: 5005131
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Biguanides in the treatment of obesity].
    Giulietti M.
    Clin Ter; 1978 Jan 15; 84(1):99-100. PubMed ID: 415837
    [No Abstract] [Full Text] [Related]

  • 4. Long term observations with oral hypoglycemic drugs: sulphonylureas, biguanides and their combination.
    Patel JC, Dhirawani MK, Doshi JC.
    Indian J Med Sci; 1970 Jul 15; 24(7):393-403. PubMed ID: 5523184
    [No Abstract] [Full Text] [Related]

  • 5. The clinical evaluation of an oral antidiabetic drug.
    Müller R.
    Aust N Z J Med; 1971 Aug 15; 1():Suppl 2:39-46. PubMed ID: 5005130
    [No Abstract] [Full Text] [Related]

  • 6. Oral management of uncomplicated maturity onset diabetes.
    Mashaly M, el-Ebrashy N, Higazi AM, Einen MA, Aziz MT.
    J Egypt Med Assoc; 1974 Aug 15; 57(7-8):288-97. PubMed ID: 4217809
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical testing of a sulphonylurea derivative, glibornuride].
    Zöllner N, Dörfler H, Wolfram G.
    Dtsch Med Wochenschr; 1972 Jul 21; 97(29):1083-8. PubMed ID: 4625427
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of a new oral drug in the treatment of diabetes mellitus].
    Lubetzki J.
    Diabete; 1971 Jul 21; 19(3):185-90. PubMed ID: 5002990
    [No Abstract] [Full Text] [Related]

  • 9. Glibenclamide (HB 419, Daonil) in the clinical practice of diabetes.
    Krall LP, Sinha S, Goldstein HH.
    Aust N Z J Med; 1971 Aug 21; 1():Suppl 2:57-62. PubMed ID: 5005132
    [No Abstract] [Full Text] [Related]

  • 10. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB.
    Journ Annu Diabetol Hotel Dieu; 1984 Aug 21; ():183-91. PubMed ID: 6443219
    [No Abstract] [Full Text] [Related]

  • 11. [Glibenclamide, a new oral antidiabetic].
    Edlén A.
    Lakartidningen; 1972 Jan 19; 69(4):342-3. PubMed ID: 4622487
    [No Abstract] [Full Text] [Related]

  • 12. [New aspects of therapy with oral antidiabetic agents].
    Haslbeck M.
    Wien Med Wochenschr; 1979 Dec 30; 199(24):689-95. PubMed ID: 161940
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Controlled extension of oral antidiabetic therapy on former insulin dependent diabetics by means of the combined i.v. glibenclamide-glucose-response-test.
    Pfeiffer EF, Raptis S.
    Diabetologia; 1972 Feb 30; 8(1):41-7. PubMed ID: 4623790
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative tolerability profiles of oral antidiabetic agents.
    Krentz AJ, Ferner RE, Bailey CJ.
    Drug Saf; 1994 Oct 30; 11(4):223-41. PubMed ID: 7848543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.